Food, Drugs, and Cosmetics - Gene Structure- and Function-Modifying Products - Labeling
Withdrawn by Sponsor (Senate)
Email me when SB 124 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 124. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would prohibit the sale of any product that modifies gene structure or function unless it is labeled prominently with the phrase “gene structure‑ or function‑modifying product” and a list of all reasonably possible risks. It targets manufacturers, distributors, and retailers of such biotech products, imposing criminal and civil penalties for violations. The measure received an unfavorable report in the Senate and was subsequently withdrawn.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 124
3 free questions a day, no accountHistory
- Withdrawn by Sponsor
- First Reading Finance
- Pre-filed
Sponsors
- Benson · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 124 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 124 freeOr ask your AI assistant about SB 124 directly:
Add to Claude, ChatGPT or Cursor